THOMSON LAUNCHES ITS 2005 LIQUENT REGULATORY AFFAIRS TRENDS SURVEY

Thousands of Pharmaceutical Professionals are Targeted to Contribute to this Premier Benchmark of Global Regulatory Trends

 

Philadelphia, Pennsylvania, USA - April 14th, 2005 — Today, Thomson Scientific & Healthcare, the global leader in providing regulatory software solutions, information products and related services for the life sciences industry, announced that its 2005 Liquent Regulatory Affairs Trends Survey is underway. Pharmaceutical regulatory professionals are invited to participate in the survey which provides insight and perspective into how regulatory departments use technology and how they plan to harness technology in the future. The survey, which will gather input through to mid May and publish its findings at the end of June, is today recognized as the premier benchmark of global regulatory submissions trends. Thomson Scientific & Healthcare is part of The Thomson Corporation (NYSE: TOC; TSX: TOC).

This year's global survey, which is expected to yield substantial responses from Europe and North America, concentrates on four key areas; Technology Usage Trends including both submission publishing software and other desktop software, Document Management System usage, Regulatory Outsourcing trends, and Regulatory trends including use or future use of the eCTD . Additionally this year's survey will also address the broader regulatory product management needs including registration management, submission project management and product information management both today and in the future.

Chronicled in previous years by several global life science industry publications and widely sourced, the Liquent Regulatory Affairs Trends Survey 2005 promises to provide new insights into how life science professionals are embracing technology, responding to rapid regulatory change, and handling the deadline pressures of mission-critical regulatory submissions.

Jim Nichols is Liquent's Vice President of Product Strategy and Marketing and is driving this worldwide initiative. "The survey contributes significantly to advancing our understanding of the distinct needs of the global regulatory market and helps us to build upon our leadership position by creating an ongoing dialogue with key regulatory professionals across North America and Europe." Jim continues, "As a part of Thomson Scientific, we are now significantly better placed to anticipate market needs and develop best in class technologies and partnerships that will underpin the regulatory product management needs of our clients and prospects."

The summary of findings, which is expected to be distributed to authorized participants in late June 2005, is already attracting interest from regulatory affairs professionals, publishers and conference organisers. For more information on the survey and how to participate please contact Kathleen Corry at Kathleen.corry@thomson.com or visit www.insightexpress.com/s/Regu84250. Editors and writers are invited to liaise with the Survey PR contact, listed at the top of this release.

About Liquent regulatory solutions

Liquent regulatory solutions provides software, information products, and related services for the life sciences industry. These solutions and services help ensure clients meet the strict standards of regulatory authorities across the world helping them achieve quality, accuracy, and data integrity to deliver regulatory reports and submissions reliably and on time. In addition to technology and services, the Liquent IDRAC database service provides the most comprehensive intelligence on the drug and biologics regulatory environment in 38 of the largest markets in the world.

As a result, 48 of the top 50 global life sciences companies rely on Liquent regulatory solutions to stay current with the latest intelligence and to provide the technology and services to compress the regulatory submissions and approval process, improving speed to market, cost control, and productivity, all of which contribute to ensuring patients' and physicians' timely access to new drugs. Over the last decade, more than 5,000 regulatory submissions have been produced using Liquent world-class products and expert services. For more information please visit, www.liquent.com.


Thomson Reuters (www.thomsonreuters.com), with 2005 revenues of approximately $8.5 billion, is a global leader in providing integrated information solutions to business and professional customers. Thomson provides value-added information, software tools and applications to more than 20 million users in the fields of law, tax, accounting, financial services, higher education, reference information, corporate e-learning and assessment, scientific research and healthcare. With operational headquarters in Stamford, Conn., Thomson has approximately 40,500 employees and provides services in approximately 130 countries. The Corporation’s common shares are listed on the New York and Toronto stock exchanges (NYSE: TOC; TSX: TOC).

Scientific is a business of Thomson Reuters. Its information solutions assist professionals at every stage of research and development—from discovery to analysis to product development and distribution. Thomson scientific information solutions can be found at www.scientific.thomson.com.



Media Contact

Ryan Sheppard
+44 20 7433 4699